Long-term Safety of Epoetin Alfa-epbx for the Treatment of Anemia in ESKD: Pooled Analyses of Randomized and Open-label Studies

RATIONALE & OBJECTIVE: Epoetin alfa-epbx is a biosimilar to the reference product, epoetin alfa. We compare the safety of epoetin alfa-epbx versus epoetin alfa based on a pooled analysis of findings from 2 randomized, double-blind, comparative clinical studies, and report new data for the long-t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Kidney Med
Glavni autori: Wish, Jay B., Rocha, Marcelo G., Martin, Nancy E., Reyes, Christian Russel D., Fishbane, Steven, Smith, Mark T., Nassar, George
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7380401/
https://ncbi.nlm.nih.gov/pubmed/32734207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2019.06.009
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items